Aprea Therapeutics, Inc. (APRE)

Operating Expenses

$13.22M

TTM · Period ending: · USD

APRE logo

APRE Operating Expenses

Latest reported$13.22M
APRE Operating Expenses ($15.85M → $13.22M)
High-resolution chart · PNG

APRE operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aprea Therapeutics, Inc. Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
13,233,836
6,458,699
16,048,142
96,989,955
37,174,676
52,811,212
29,374,044
16,489,403
15,852,375
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.